ACTREC

PG degree with PhD in Life Sciences or related fields. Preclinical Animal Study of the Efficacy and Safety of AIP- 303, a Theragnostic Radioimmunoconjugate for Invasive Breast Cancer Targeting Angiogenesis. Advanced Centre for Treatment, Research and Education in Cancer ACTREC

Masters Degree in Life Sciences or Bachelors Degree in Engineering or Technology and Doctoral Degree (PhD) in Science / Engineering / Technology / Pharma / MD / MS from a recognized university

PhD degree in life sciences with experiences in using different in silico based tools and data- bases design. Advanced Centre for Treatment, Research and Education in Cancer ACTREC

M.Pharm / M.Sc in Pharmaceutical Sciences / Pharmaceutics / Chemistry with specialization in Organic / Medicinal Chemistry / Life Science / Biotechnology with GATE/GPAT.

M.Sc. in Life Sciences with minimum 60% marks in the qualifying exam with CSIR-UGC NET and GATE qualification. Candidate with experience in R, Python programming, and high throughput genomic data analyses will be given preference

Post Graduation in Science with P.G. Diploma in Clinical Research is Mandatory. Candidates with minimum 6 months experience in handling regulatory trials would be desirable.

M.Sc. / M.Tech Microbiology / Biotechnology / Life Sciences / Zoology / Medical or Human Genetics / Biochemistry/ Molecular Biology/ Botany / Applied Biology/Cytogenetics.

Doctoral Degree in Science / Engineering / Technology / Pharma / MD / MS from a recognized university or equivalent.

M.Sc in Life Sciences. Experience in immuno-fluorescence. To work on project in Translational Research Laboratory. Area of research is DNA damage repair and cancer